-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcus Biosciences Refocuses R&D on Casdatifan and Inflammation Programs, Plans New Clinical Trials and Data Readouts Through 2028

Reuters·12/12/2025 13:30:31

Please log in to view news